864 related articles for article (PubMed ID: 7596372)
41. Genetics and Gene Therapy of Anderson-Fabry Disease.
Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
[TBL] [Abstract][Full Text] [Related]
42. Screening for Fabry disease in left ventricular hypertrophy: documentation of a novel mutation.
Baptista A; Magalhães P; Leão S; Carvalho S; Mateus P; Moreira I
Arq Bras Cardiol; 2015 Aug; 105(2):139-44. PubMed ID: 26269958
[TBL] [Abstract][Full Text] [Related]
43. Intermittent claudication unmasking underlying Fabry's disease.
Diamantopoulos EJ; Andreadis EA; Vassilopoulos CV; Marakomichelakis GE
Int Angiol; 2002 Jun; 21(2):201-3. PubMed ID: 12110785
[TBL] [Abstract][Full Text] [Related]
44. Relief of left ventricular outflow obstruction by cibenzoline in a patient with Fabry's disease--a case report.
Morimoto S; Sugiura A; Iwase M; Kubo N; Hiramitsu S; Uemura A; Ohtsuki M; Kato S; Kato Y; Hishida H
Angiology; 2006; 57(2):241-5. PubMed ID: 16518535
[TBL] [Abstract][Full Text] [Related]
45. [Fabry's disease associated with rheumatoid arthritis. Multisystemic crossroads].
Arias Martínez N; Barbado Hernández FJ; Pérez Martín G; Pérez de Ayala C; Casal Esteban V; Vázquez Rodríguez JJ
An Med Interna; 2003 Jan; 20(1):28-30. PubMed ID: 12666306
[TBL] [Abstract][Full Text] [Related]
46. Identification of novel mutations in the α-galactosidase A gene in patients with Fabry disease: pitfalls of mutation analyses in patients with low α-galactosidase A activity.
Yoshimitsu M; Higuchi K; Miyata M; Devine S; Mattman A; Sirrs S; Medin JA; Tei C; Takenaka T
J Cardiol; 2011 May; 57(3):345-53. PubMed ID: 21333496
[TBL] [Abstract][Full Text] [Related]
47. High incidence of thrombosis in Fabry's disease.
Utsumi K; Yamamoto N; Kase R; Takata T; Okumiya T; Saito H; Suzuki T; Uyama E; Sakuraba H
Intern Med; 1997 May; 36(5):327-9. PubMed ID: 9213168
[TBL] [Abstract][Full Text] [Related]
48. [Fabry disease in light of recent review].
Uyama E
Brain Nerve; 2008 Nov; 60(11):1235-44. PubMed ID: 19069157
[TBL] [Abstract][Full Text] [Related]
49. [Fabry disease: data from four families].
Slee PH; van Boven LJ; Slee DS
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2412-5. PubMed ID: 11145098
[TBL] [Abstract][Full Text] [Related]
50. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.
Massaccesi L; Burlina A; Baquero CJ; Goi G; Burlina AP; Tettamanti G
Clin Biochem; 2011 Jul; 44(10-11):916-21. PubMed ID: 21515249
[TBL] [Abstract][Full Text] [Related]
51. Clinical features and genetic analysis of a Chinese kindred with Fabry's disease.
Tse KC; Chan KW; Tin VP; Yip PS; Tang S; Li FK; Ho YW; Lai KN; Chan TM
Nephrol Dial Transplant; 2003 Jan; 18(1):182-6. PubMed ID: 12480979
[TBL] [Abstract][Full Text] [Related]
52. Pediatric Fabry disease.
Ries M; Gupta S; Moore DF; Sachdev V; Quirk JM; Murray GJ; Rosing DR; Robinson C; Schaefer E; Gal A; Dambrosia JM; Garman SC; Brady RO; Schiffmann R
Pediatrics; 2005 Mar; 115(3):e344-55. PubMed ID: 15713906
[TBL] [Abstract][Full Text] [Related]
53. [Enzyme replacement therapy in Fabry's disease].
Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
[TBL] [Abstract][Full Text] [Related]
54. [Cardiac manifestation of Fabry's disease: current knowledge].
Palecek T; Lubanda JC; Magage S; Karetová D; Bultas J; Linhart A
Vnitr Lek; 2004 Nov; 50(11):846-51. PubMed ID: 15648965
[TBL] [Abstract][Full Text] [Related]
55. Adult polyglucosan body disease in a patient originally diagnosed with Fabry's disease.
Sagnelli A; Savoiardo M; Marchesi C; Morandi L; Mora M; Morbin M; Farina L; Mazzeo A; Toscano A; Pagliarani S; Lucchiari S; Comi GP; Salsano E; Pareyson D
Neuromuscul Disord; 2014 Mar; 24(3):272-6. PubMed ID: 24380807
[TBL] [Abstract][Full Text] [Related]
56. Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes.
Ashton-Prolla P; Tong B; Shabbeer J; Astrin KH; Eng CM; Desnick RJ
J Investig Med; 2000 Jul; 48(4):227-35. PubMed ID: 10916280
[TBL] [Abstract][Full Text] [Related]
57. Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study.
Yeniçerioğlu Y; Akdam H; Dursun B; Alp A; Sağlam Eyiler F; Akın D; Gün Y; Hüddam B; Batmazoğlu M; Gibyeli Genek D; Pirinççi S; Ersoy İR; Üzüm A; Soypaçacı Z; Tanrısev M; Çolak H; Demiral Sezer S; Bozkurt G; Akyıldız UO; Akyüz Ünsal Aİ; Ünübol M; Uslu M; Eryılmaz U; Günel C; Meteoğlu İ; Yavaşoğlu İ; Ünsal A; Akar H; Okyay P
Ren Fail; 2017 Nov; 39(1):104-111. PubMed ID: 27832731
[TBL] [Abstract][Full Text] [Related]
58. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.
Mahmud HM
J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811
[TBL] [Abstract][Full Text] [Related]
59. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C
Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492
[TBL] [Abstract][Full Text] [Related]
60. Fabry's disease presenting with stroke.
Grewal RP; Barton NW
Clin Neurol Neurosurg; 1992; 94(2):177-9. PubMed ID: 1324819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
